EXPLOITING RECURRENT CHROMATIN MODIFIER MUTATIONS FOR PROSTATE CANCER TARGETED THERAPY

$1,055,795FY2019Department of the ArmyDOD

Fred Hutchinson Cancer Research Center, Seattle WA

Investigators